questionsmedicales.fr
Composés chimiques organiques
Hydrocarbures
Hydrocarbures cycliques
Hydrocarbures aromatiques
Dérivés du benzène
Composés benzyliques
Composés benzyliques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Exposition professionnelle
Tests biologiques
Analyse sanguine
Analyse urinaire
Marqueurs biologiques
Métabolites
Évaluation des risques
Conditions de travail
Symptômes
5
Irritation cutanée
Maux de tête
Allergies
Réactions cutanées
Troubles neurologiques
Problèmes respiratoires
Enfants
Troubles du comportement
Prévention
5
Prévention
Équipements de protection
Réglementations
Industrie
Travailleurs
Formations de sécurité
Évaluations de risque
Entreprises
Sensibilisation
Campagnes d'information
Traitements
5
Intoxication
Soins symptomatiques
Antidotes
Traitement symptomatique
Irritations cutanées
Crèmes apaisantes
Complications
5
Complications
Troubles respiratoires
Cancers
Exposition prolongée
Gestion des complications
Suivi médical
Effets à long terme
Santé
Facteurs de risque
5
Facteurs de risque
Industrie chimique
Mode de vie
Produits chimiques
Travailleurs de la santé
Médicaments
Environnements industriels
Laboratoires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Composés benzyliques : Questions médicales les plus fréquentes",
"headline": "Composés benzyliques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Composés benzyliques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-26",
"dateModified": "2025-02-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Composés benzyliques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Dérivés du benzène",
"url": "https://questionsmedicales.fr/mesh/D001555",
"about": {
"@type": "MedicalCondition",
"name": "Dérivés du benzène",
"code": {
"@type": "MedicalCode",
"code": "D001555",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Alcools benzyliques",
"alternateName": "Benzyl Alcohols",
"url": "https://questionsmedicales.fr/mesh/D001592",
"about": {
"@type": "MedicalCondition",
"name": "Alcools benzyliques",
"code": {
"@type": "MedicalCode",
"code": "D001592",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.140.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Alcool benzylique",
"alternateName": "Benzyl Alcohol",
"url": "https://questionsmedicales.fr/mesh/D019905",
"about": {
"@type": "MedicalCondition",
"name": "Alcool benzylique",
"code": {
"@type": "MedicalCode",
"code": "D019905",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.140.200.100"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Benzylamines",
"alternateName": "Benzylamines",
"url": "https://questionsmedicales.fr/mesh/D001596",
"about": {
"@type": "MedicalCondition",
"name": "Benzylamines",
"code": {
"@type": "MedicalCode",
"code": "D001596",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.140.210"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Pargyline",
"alternateName": "Pargyline",
"url": "https://questionsmedicales.fr/mesh/D010293",
"about": {
"@type": "MedicalCondition",
"name": "Pargyline",
"code": {
"@type": "MedicalCode",
"code": "D010293",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.140.210.650"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Bibenzyles",
"alternateName": "Bibenzyls",
"url": "https://questionsmedicales.fr/mesh/D001632",
"about": {
"@type": "MedicalCondition",
"name": "Bibenzyles",
"code": {
"@type": "MedicalCode",
"code": "D001632",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.140.308"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lignanes",
"alternateName": "Lignans",
"url": "https://questionsmedicales.fr/mesh/D017705",
"about": {
"@type": "MedicalCondition",
"name": "Lignanes",
"code": {
"@type": "MedicalCode",
"code": "D017705",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.140.450"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Composés benzyliques",
"alternateName": "Benzyl Compounds",
"code": {
"@type": "MedicalCode",
"code": "D001593",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Alexander P Atkins",
"url": "https://questionsmedicales.fr/author/Alexander%20P%20Atkins",
"affiliation": {
"@type": "Organization",
"name": "University of Bristol, School of Chemistry, Bristol, BS8 1TS, U.K."
}
},
{
"@type": "Person",
"name": "Alastair J J Lennox",
"url": "https://questionsmedicales.fr/author/Alastair%20J%20J%20Lennox",
"affiliation": {
"@type": "Organization",
"name": "University of Bristol, School of Chemistry, Bristol, BS8 1TS, U.K."
}
},
{
"@type": "Person",
"name": "Hiroaki Tsuji",
"url": "https://questionsmedicales.fr/author/Hiroaki%20Tsuji",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, College of Humanities & Sciences, Nihon University, Sakurajosui, Setagaya-ku, Tokyo 156-8550, Japan. tsuji@chs.nihon-u.ac.jp kawatsur@chs.nihon-u.ac.jp."
}
},
{
"@type": "Person",
"name": "Motoi Kawatsura",
"url": "https://questionsmedicales.fr/author/Motoi%20Kawatsura",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, College of Humanities & Sciences, Nihon University, Sakurajosui, Setagaya-ku, Tokyo 156-8550, Japan. tsuji@chs.nihon-u.ac.jp kawatsur@chs.nihon-u.ac.jp."
}
},
{
"@type": "Person",
"name": "Yan-Hong He",
"url": "https://questionsmedicales.fr/author/Yan-Hong%20He",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Completeness of variables in Hospital-Based Cancer Registries for prostatic malignant neoplasm.",
"datePublished": "2024-07-29",
"url": "https://questionsmedicales.fr/article/39082550",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/0034-7167-2023-0467"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hepatic Small Vessel Neoplasm Mimics Prostate Cancer on 18 F-DCFPyl PET/CT.",
"datePublished": "2023-01-14",
"url": "https://questionsmedicales.fr/article/36728165",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RLU.0000000000004554"
}
},
{
"@type": "ScholarlyArticle",
"name": "Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37850783",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23750/abm.v94i5.13751"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer.",
"datePublished": "2022-12-27",
"url": "https://questionsmedicales.fr/article/36572885",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12957-022-02841-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "The influence of prostate volume on clinical parameters in prostate cancer screening.",
"datePublished": "2022-09-13",
"url": "https://questionsmedicales.fr/article/36098911",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jcla.24700"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Composés benzyliques",
"item": "https://questionsmedicales.fr/mesh/D001593"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Composés benzyliques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Composés benzyliques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Composés benzyliques",
"description": "Comment diagnostiquer une exposition aux composés benzyliques ?\nQuels tests sont utilisés pour détecter les composés benzyliques ?\nQuels symptômes indiquent une intoxication aux composés benzyliques ?\nY a-t-il des marqueurs biologiques pour les composés benzyliques ?\nComment évaluer le risque d'exposition aux composés benzyliques ?",
"url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Prostatic+Neoplasms#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Composés benzyliques",
"description": "Quels sont les symptômes courants d'une exposition aux composés benzyliques ?\nLes composés benzyliques provoquent-ils des allergies ?\nQuels effets à long terme peuvent résulter d'une exposition ?\nLes symptômes varient-ils selon le type de composé ?\nComment les symptômes se manifestent-ils chez les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Prostatic+Neoplasms#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Composés benzyliques",
"description": "Comment prévenir l'exposition aux composés benzyliques ?\nY a-t-il des réglementations pour l'utilisation de ces composés ?\nQuels conseils donner aux travailleurs exposés ?\nLes entreprises doivent-elles effectuer des évaluations de risque ?\nComment sensibiliser le public aux dangers des composés benzyliques ?",
"url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Prostatic+Neoplasms#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Composés benzyliques",
"description": "Quel traitement est recommandé en cas d'intoxication ?\nDes antidotes existent-ils pour les composés benzyliques ?\nComment traiter les irritations cutanées causées par ces composés ?\nLes traitements varient-ils selon l'âge du patient ?\nQuels soins d'urgence sont nécessaires en cas d'exposition aiguë ?",
"url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Prostatic+Neoplasms#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Composés benzyliques",
"description": "Quelles complications peuvent survenir après une exposition prolongée ?\nLes composés benzyliques peuvent-ils causer des cancers ?\nComment les complications sont-elles gérées ?\nLes complications varient-elles selon le type de composé ?\nQuels sont les effets à long terme sur la santé ?",
"url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Prostatic+Neoplasms#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Composés benzyliques",
"description": "Quels sont les principaux facteurs de risque d'exposition ?\nLes enfants sont-ils plus à risque d'exposition ?\nComment le mode de vie influence-t-il le risque d'exposition ?\nLes travailleurs de la santé sont-ils à risque ?\nQuels environnements présentent un risque accru ?",
"url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Prostatic+Neoplasms#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une exposition aux composés benzyliques ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les composés benzyliques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter ces composés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication aux composés benzyliques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des nausées et des irritations cutanées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques pour les composés benzyliques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des métabolites spécifiques peuvent être mesurés dans les fluides corporels."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque d'exposition aux composés benzyliques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation des conditions de travail et des habitudes de vie est nécessaire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une exposition aux composés benzyliques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des irritations cutanées, des maux de tête et des vertiges."
}
},
{
"@type": "Question",
"name": "Les composés benzyliques provoquent-ils des allergies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent développer des réactions allergiques aux composés benzyliques."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme peuvent résulter d'une exposition ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut entraîner des troubles neurologiques et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de composé ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la structure chimique et de la dose."
}
},
{
"@type": "Question",
"name": "Comment les symptômes se manifestent-ils chez les enfants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes plus graves, comme des troubles du comportement."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux composés benzyliques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des réglementations pour l'utilisation de ces composés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réglementations strictes encadrent leur utilisation dans l'industrie et la recherche."
}
},
{
"@type": "Question",
"name": "Quels conseils donner aux travailleurs exposés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre les formations de sécurité et signaler toute exposition suspecte immédiatement."
}
},
{
"@type": "Question",
"name": "Les entreprises doivent-elles effectuer des évaluations de risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les entreprises doivent régulièrement évaluer les risques liés à l'exposition."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser le public aux dangers des composés benzyliques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Organiser des campagnes d'information et des formations sur les risques associés."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé en cas d'intoxication ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend l'élimination de l'exposition et des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les composés benzyliques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées causées par ces composés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des crèmes apaisantes et éviter tout contact avec le composé irritant."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon l'âge du patient ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction de l'âge et de la santé générale."
}
},
{
"@type": "Question",
"name": "Quels soins d'urgence sont nécessaires en cas d'exposition aiguë ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les soins d'urgence incluent le lavage des zones exposées et l'administration d'oxygène si nécessaire."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une exposition prolongée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des troubles respiratoires et des effets neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les composés benzyliques peuvent-ils causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien potentiel entre l'exposition prolongée et certains cancers."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical régulier et des traitements adaptés."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le type de composé ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent varier en fonction de la structure chimique et de la dose."
}
},
{
"@type": "Question",
"name": "Quels sont les effets à long terme sur la santé ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme peuvent inclure des troubles neurologiques et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'exposition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent le travail dans l'industrie chimique et l'utilisation domestique."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque d'exposition ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants sont plus vulnérables en raison de leur comportement exploratoire."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il le risque d'exposition ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie impliquant l'utilisation de produits chimiques augmente le risque d'exposition."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs de la santé peuvent être exposés lors de l'utilisation de certains médicaments."
}
},
{
"@type": "Question",
"name": "Quels environnements présentent un risque accru ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les environnements industriels et de laboratoire présentent un risque accru d'exposition."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 20/02/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
University of Bristol, School of Chemistry, Bristol, BS8 1TS, U.K.
Publications dans "Composés benzyliques" :
3 publications dans cette catégorie
Affiliations :
University of Bristol, School of Chemistry, Bristol, BS8 1TS, U.K.
Publications dans "Composés benzyliques" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, College of Humanities & Sciences, Nihon University, Sakurajosui, Setagaya-ku, Tokyo 156-8550, Japan. tsuji@chs.nihon-u.ac.jp kawatsur@chs.nihon-u.ac.jp.
Publications dans "Composés benzyliques" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, College of Humanities & Sciences, Nihon University, Sakurajosui, Setagaya-ku, Tokyo 156-8550, Japan. tsuji@chs.nihon-u.ac.jp kawatsur@chs.nihon-u.ac.jp.
Publications dans "Composés benzyliques" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China.
Publications dans "Composés benzyliques" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China.
Publications dans "Composés benzyliques" :
2 publications dans cette catégorie
Affiliations :
Roy and Diana Vagelos Laboratories, Penn/Merck Laboratory for High-Throughput Experimentation, Department of Chemistry, University of Pennsylvania 231 South 34th Street Philadelphia Pennsylvania 19104-6323 USA pwalsh@sas.upenn.edu.
Department of Chemistry, Renmin University of China Beijing 100872 China 20050062@ruc.edu.cn.
Publications dans "Composés benzyliques" :
2 publications dans cette catégorie
Affiliations :
Roy and Diana Vagelos Laboratories, Penn/Merck Laboratory for High-Throughput Experimentation, Department of Chemistry, University of Pennsylvania 231 South 34th Street Philadelphia Pennsylvania 19104-6323 USA pwalsh@sas.upenn.edu.
Publications dans "Composés benzyliques" :
2 publications dans cette catégorie
Affiliations :
Roy and Diana Vagelos Laboratories, Penn/Merck Laboratory for High-Throughput Experimentation, Department of Chemistry, University of Pennsylvania 231 South 34th Street Philadelphia Pennsylvania 19104-6323 USA pwalsh@sas.upenn.edu.
Publications dans "Composés benzyliques" :
2 publications dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Johannesburg, PO Box 524, Auckland Park, 2006, Johannesburg, South Africa.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Indian Institute of Technology Kharagpur Kharagpur 721302 India mxb@iitkgp.ac.in.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Indian Institute of Technology Kharagpur Kharagpur 721302 India mxb@iitkgp.ac.in.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Indian Institute of Technology Kharagpur Kharagpur 721302 India mxb@iitkgp.ac.in.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education and School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an, 710119, China.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education and School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an, 710119, China.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education and School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an, 710119, China.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, University of Liverpool, Liverpool, L69 7ZD, UK.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, University of Liverpool, Liverpool, L69 7ZD, UK.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education and School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an, 710119, China.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education and School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an, 710119, China.
Publications dans "Composés benzyliques" :
to analyze the completeness of variables from Hospital-Based Cancer Registries of cases of prostate neoplasm in the Oncology Care Network of a Brazilian state between 2000 and 2020....
an ecological time series study, based on secondary data on prostate cancer Hospital-Based Cancer Registries prostate. Data incompleteness was classified as excellent (<5%), good (between 5%-10%), fai...
there were 13,519 cases of prostate cancer in the Hospital-Based Cancer Registries analyzed. The variables "family history of cancer" (p<0.001), "alcoholism" (p<0.001), "smoking" (p<0.001), "TNM stagi...
most Hospital-Based Cancer Registries variables showed excellent completeness, but important variables had high percentages of incompleteness, such as TNM and clinical staging, in addition to alcoholi...
18 F-DCFPyl is a Food and Drug Administration-approved radiotracer that targets prostate-specific membrane antigen and is used in the detection of recurrent or metastatic prostate cancer. As its use h...
We report the case of a 63-year-old male who came to the urology clinic with an increasing value of the prostate specific antigen and an asymmetrical enlargement at the digital rectal examination. The...
Biomarkers of DNA damage repair deficiency provide opportunities for personalized treatment with immunotherapy. However, there is limited research on the immune microenvironment of adeno-neuroendocrin...
A retrospective medical record review of 66 patients with prostate cancer (PCa) was performed. PCa samples from the 66 patients were analyzed using immunohistochemical staining for the detection of ch...
Twenty patients presented with adeno-NEPC, whereas 46 presented with adeno-PCa. The median age of patients at PCa diagnosis was 67.86 ± 7.05 years (68.65 ± 7.23 years, adeno-NEPC; 67.52 ± 7.02 years, ...
Our study revealed clinicopathological manifestations of adeno-NEPC and some possible predictive factors significantly associated with better outcomes in patients with adeno-NEPC. These findings might...
The purpose of the study was to evaluate the diagnostic significance of two new and a few clinical markers for prostate cancer (PCa) at various prostate volumes (PV)....
The study subjects were divided into two groups. Among them, there were 70 cases in the PV ≤30 ml group (benign prostatic hyperplasia [BPH]: 32 cases, PCa: 38 cases) and 372 cases in the PV > 30 ml gr...
In the PV ≤30 ml group, the diagnostic parameters based on prostate-specific antigen (PSA) had a decreased diagnostic significance for PCa. In the PV > 30 ml group, PSAD (AUC = 0.709), AVR (AVR = Age/...
Choosing appropriate indicators for different PVs could contribute to the early screening and diagnosis of PCa. The difference in the diagnostic value of two new indicators (A-PSAD and AVR), and PSAD ...
The optimal treatment of metastatic castration-resistant prostate cancer (mCRPC) continues to be challenging, given the multitude of life prolonging treatment options. Radionuclide therapy delivers co...
This study aims to compare the ability of the PHI versus tPSA test to predict the presence of PCa in our population....
A prospective observational study was performed. We included patients with tPSA ≥ 2.5 ng/ml, biopsy naïve or previous negative biopsy, undergoing a blood test, which includes tPSA, fPSA, and p2PSA, an...
140 men were included. Fifty-seven (40.7%) had a positive prostate biopsy result (Group A), and 83 (59.3%) had a negative biopsy result (Group B). The mean age was similar in both groups (mean ± stand...
The PHI test improves PCa detection compared to tPSA in our population....
Holmium laser enucleation of the prostate (HoLEP) is a size-independent surgical option for treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with excellent, durable ...
Noninvasive methods for the early identify diagnosis of prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCa) are current clinical challenges....
The serum metabolites of 20 healthy individuals and patients with prostatitis, BPH, or PCa were identified using untargeted liquid chromatography-mass spectrometry (LC-MS). In addition, targeted LC-MS...
Organic acid metabolites had good sensitivity and specificity in differentiating prostatitis, BPH, and PCa. Three diagnostic models identified patients with PROSTATITIS: phenyllactic acid (area under ...
We compare Prostate Health Index, Prostate Health Index density, and PSA density in predicting clinically significant prostate cancer in MRI-guided prostate biopsy....
This is a multicenter evaluation of prospectively maintained prostate biopsy databases at 10 urology centers. Men with Prostate Health Index and MRI-guided targeted and systematic prostate biopsy perf...
A total of 1,215 men were analyzed. Prostate cancer and clinically significant prostate cancer were diagnosed in 51% (617/1,215) and 35% (422/1,215) of men, respectively. Clinically significant prosta...
Prostate Health Index density outperformed Prostate Health Index or PSA density in clinically significant prostate cancer detection in men with multiparametric MRI performed, and further reduced unnec...